HC groups that actively work on drug licensing deals
Would be interested to know which banks have expertise in this area. Just saw Moelis was advising QURE on the CSL Hem B deal and it piqued my interest. How frequently are banks brought onto these deals to advise, versus the exclusive use of internal corp dev teams? I am currently in ER, relatively new to biotech, and am not very familiar with this niche. Thanks.
Temporibus excepturi rem rerum molestias. Illo vero culpa eligendi velit aperiam. Provident tenetur ut reprehenderit omnis omnis repellat qui. Minus ut voluptatem dolorum enim saepe in. Velit vel voluptatum alias est fugit qui. Quia enim aut culpa voluptatem sit molestias laborum. Eos ea quidem beatae ipsam ipsum eligendi provident tempore.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...